These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

590 related items for PubMed ID: 25388377

  • 1. Prevalence of myasthenia gravis and associated autoantibodies in paraneoplastic pemphigus and their correlations with symptoms and prognosis.
    Wang R, Li J, Wang M, Hao H, Chen X, Li R, Zhu X.
    Br J Dermatol; 2015 Apr; 172(4):968-75. PubMed ID: 25388377
    [Abstract] [Full Text] [Related]

  • 2. Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.
    Mygland A, Vincent A, Newsom-Davis J, Kaminski H, Zorzato F, Agius M, Gilhus NE, Aarli JA.
    Arch Neurol; 2000 Apr; 57(4):527-31. PubMed ID: 10768628
    [Abstract] [Full Text] [Related]

  • 3. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies.
    Romi F, Skeie GO, Aarli JA, Gilhus NE.
    Arch Neurol; 2000 Nov; 57(11):1596-600. PubMed ID: 11074791
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Autoantibody profile and clinical characteristics in a cohort of Chinese adult myasthenia gravis patients.
    Hong Y, Li HF, Skeie GO, Romi F, Hao HJ, Zhang X, Gao X, Owe JF, Gilhus NE.
    J Neuroimmunol; 2016 Sep 15; 298():51-7. PubMed ID: 27609275
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
    Nikolic A, Djukic P, Basta I, Hajdukovic Lj, Stojanovic VR, Stevic Z, Nikolic D, Bozic V, Lavrnic S, Lavrnic D.
    Clin Neurol Neurosurg; 2013 Apr 15; 115(4):432-7. PubMed ID: 22770539
    [Abstract] [Full Text] [Related]

  • 10. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
    Rigamonti A, Lauria G, Piamarta F, Fiumani A, Agostoni E.
    J Neurol Sci; 2011 Mar 15; 302(1-2):112-3. PubMed ID: 21236448
    [Abstract] [Full Text] [Related]

  • 11. Muscle autoantibodies in subgroups of myasthenia gravis patients.
    Romi F, Skeie GO, Aarli JA, Gilhus NE.
    J Neurol; 2000 May 15; 247(5):369-75. PubMed ID: 10896269
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis.
    Mygland A, Aarli JA, Matre R, Gilhus NE.
    J Neurol Neurosurg Psychiatry; 1994 Jul 15; 57(7):843-6. PubMed ID: 8021674
    [Abstract] [Full Text] [Related]

  • 14. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
    Mygland A, Tysnes OB, Matre R, Volpe P, Aarli JA, Gilhus NE.
    Ann Neurol; 1992 Oct 15; 32(4):589-91. PubMed ID: 1333745
    [Abstract] [Full Text] [Related]

  • 15. Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules.
    Romi F, Bø L, Skeie GO, Myking A, Aarli JA, Gilhus NE.
    J Neuroimmunol; 2002 Jul 15; 128(1-2):82-9. PubMed ID: 12098514
    [Abstract] [Full Text] [Related]

  • 16. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
    Farrugia ME, Robson MD, Clover L, Anslow P, Newsom-Davis J, Kennett R, Hilton-Jones D, Matthews PM, Vincent A.
    Brain; 2006 Jun 15; 129(Pt 6):1481-92. PubMed ID: 16672291
    [Abstract] [Full Text] [Related]

  • 17. Myasthenia gravis sera containing antiryanodine receptor antibodies inhibit binding of [3H]-ryanodine to sarcoplasmic reticulum.
    Skeie GO, Lunde PK, Sejersted OM, Mygland A, Aarli JA, Gilhus NE.
    Muscle Nerve; 1998 Mar 15; 21(3):329-35. PubMed ID: 9486861
    [Abstract] [Full Text] [Related]

  • 18. Serological diagnostics in myasthenia gravis based on novel assays and recently identified antigens.
    Zisimopoulou P, Brenner T, Trakas N, Tzartos SJ.
    Autoimmun Rev; 2013 Jul 15; 12(9):924-30. PubMed ID: 23537507
    [Abstract] [Full Text] [Related]

  • 19. Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis.
    Cordts I, Bodart N, Hartmann K, Karagiorgou K, Tzartos JS, Mei L, Reimann J, Van Damme P, Rivner MH, Vigneron A, Weis J, Schulz JB, Tzartos SJ, Claeys KG.
    J Neurol; 2017 Jun 15; 264(6):1193-1203. PubMed ID: 28516329
    [Abstract] [Full Text] [Related]

  • 20. Multiple antibody detection in 'seronegative' myasthenia gravis patients.
    Hong Y, Zisimopoulou P, Trakas N, Karagiorgou K, Stergiou C, Skeie GO, Hao HJ, Gao X, Owe JF, Zhang X, Yue YX, Romi F, Wang Q, Li HF, Gilhus NE, Tzartos SJ.
    Eur J Neurol; 2017 Jun 15; 24(6):844-850. PubMed ID: 28470860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.